Drugmaker AbbVie scored three big wins in recent days – one in the courtroom, one in a clinical study, and one in the form of a collaboration deal. And these three wins may offer three more reasons to buy the stock. CLICK HERE.
AbbVie’s 3 For 3
- by Ashley Hayes